Company
Board Member, CEO
2024-07-22–present
Malte Peters
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Malte Peters
Malte Peters is recorded as CEO and Board Member at Tango Therapeutics, Inc. (TNGX). Tango Therapeutics, Inc. reported in an 8-K filed January 8, 2026 that Malte Peters was appointed President and Chief Executive Officer, effective January 8, 2026. The company reported in an 8-K filed July 26, 2024 that Malte Peters was appointed Chief Executive Officer, effective July 22, 2024.
“Malte Peters, M.D., current board member, appointed President and Chief Executive Officer, effective immediately”
“On July 22, 2024, the Company's board of directors (the "Board") appointed Malte Peters, M.D., as the Company's Chief Executive Officer and President, effective July 22, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-01-08–present
-
Organization not stated
CEO
SEC 8-K
Current2024-07-22–present
-
Current
2018-01-01–present
-
Organization not stated
Board Member
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Tango Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Malte Peters, M.D. CEO
- Barbara Weber, M.D. Chairman
- Matthew Gall CFO, Board Member
- Jessica Newcomb Chief Accounting Officer
- Adam Crystal Board Member
- Daniella Beckman Board Member
- James B. Avery Board Member
- John Ketchum Board Member
- Lesley Ann Calhoun Board Member
- Lesley Calhoun Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
-
Executive change Appointed: Chief Executive Officer